Abbott is most often rated as a stand-out health care stock. It is the diversified revenue stream that makes Abbott a stable company. The company off lately has been in news for its proposed acquisition of Alere Inc, a medical testing company and St. Jude Medical Inc, a device maker. Abbott is clearing space for the acquisition by selling its eye surgery equipment unit to Johnson & Johnson for $3.44Bil. The deal is expected to close in the first quarter of 2017. There is a positive reaction to Abbott stock on this move.